Compare Oatly Group AB - ADR (OTLY) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oatly Group AB - ADR vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Oatly Group AB - ADR trades at $10.59 (market cap $330.93M), while Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 76.4× Oatly Group AB - ADR's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Oatly Group AB - ADR pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oatly Group AB - ADR for 18 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| OTLY | RPRX | |
|---|---|---|
Market Cap | $330.93M | $25.27B |
Volume | 68,708 | 3,671,183 |
Sector | Consumer Staples | Health |
52-Week High | $15.91 | $63.96 |
52-Week Low | $8.03 | $35.44 |
Typical Hold Time | 18 Days | 1 Days |
Enterprise Value | $835.34M | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OTLY trades at $10.59, up 2.12% today, with a bearish technical signal but improving fundamentals. Revenue grew to $862.46M in 2025, and net losses narrowed to -$152.77M, reflecting margin improvements. The company raised its 2026 revenue outlook after Q2 results, driving positive sentiment. However, negative cash flows and high debt-to-asset ratio of 66.53% in 2025 pose risks. Analyst consensus is mixed with a $12.28 price target, indicating modest upside potential from current levels.
Outlook: OTLY shows operational progress with revenue growth and reduced losses, but profitability remains elusive. Investment opportunity hinges on sustained margin expansion and positive EBITDA. Key risks include cash burn, competitive pressures, and leverage. Investors should weigh turnaround potential against financial stability concerns.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
